Cancer BiologybioRxiv
Pituitary Carcinoma: The University of Texas MD Anderson Cancer Center Experience.
F. Santos-Pinheiro, M. Penas-Prado, C. Kamiya-Matsuoka…·I. E. McCutcheon
This study reports on 17 pituitary carcinoma patients treated at MDACC, finding that TMZ-based therapy correlates with longer disease control and higher survival rates.
DOI 10.1200/jco.2017.35.15_suppl.2068